RWA Wealth Partners LLC Acquires 565 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RWA Wealth Partners LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 60,031 shares of the healthcare conglomerate's stock after buying an additional 565 shares during the quarter. RWA Wealth Partners LLC's holdings in UnitedHealth Group were worth $30,368,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. State Street Corp grew its holdings in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after purchasing an additional 563,554 shares during the period. Geode Capital Management LLC increased its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after acquiring an additional 318,039 shares during the last quarter. Norges Bank purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. Franklin Resources Inc. increased its stake in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 0.5% in the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after buying an additional 36,394 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH traded down $0.64 during trading hours on Wednesday, reaching $522.48. The company's stock had a trading volume of 1,164,691 shares, compared to its average volume of 4,260,920. The firm has a 50-day simple moving average of $509.06 and a 200-day simple moving average of $542.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $477.92 billion, a price-to-earnings ratio of 33.71, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The business's quarterly revenue was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on UNH shares. Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $629.32.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.